Savina Jaeger

Head of Biostatistics
Spark Therapeutics, Inc.
Philadelphia, Pennsylvania, United States

Presentation(s):

• OC 20.3 - Improved Joint Health After Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011) in People with Hemophilia A

  Sunday, June 25, 2023
  15:15 – 15:30 ET

• PB0188 - Improved Quality of Life in People with Hemophilia A Following Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011)

  Sunday, June 25, 2023
  18:30 – 19:30 ET